Full Text View
Tabular View
No Study Results Posted
Related Studies
Sirolimus for Focal Segmental Glomerulosclerosis
This study has been completed.
Study NCT00040508   Information provided by National Institutes of Health Clinical Center (CC)
First Received: June 26, 2002   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Focal Glomerulosclerosis
Additional conditions recognized in this trial
Glomerulosclerosis, Focal Segmental
More general conditions related to this trial
Glomerulonephritis
Kidney Diseases
Nephritis
Urologic Diseases
Interventions listed in this trial
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services